Temporal trends in baseline characteristics and treatment outcomes of children starting antiretroviral treatment: An analysis in four provinces in South Africa, 2004-2009

Journal of Acquired Immune Deficiency Syndromes

Volumn 58, Issue 3, 2011, Pages

  Fatti, Geoffrey ^a   Bock, Peter ^a,b   Eley, Brian ^c   Mothibi, Eula ^a   Grimwood, Ashraf ^a  

^a Kheth'Impilo   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

antiretroviral therapy; baseline characteristics; children; program outcomes; South Africa; temporal trends

Indexed keywords

ANTIRETROVIRUS AGENT; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TUBERCULOSTATIC AGENT; ZIDOVUDINE;

CD4 LYMPHOCYTE COUNT; CHILD; CLINICAL ASSESSMENT; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; IMMUNOLOGICAL MONITORING; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MATERNAL CARE; MEDICAL RECORD REVIEW; MORTALITY; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVIEW; SOUTH AFRICA; TREATMENT OUTCOME; TREND STUDY; TUBERCULOSIS; VIRUS LOAD;

ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA; TREATMENT OUTCOME;

EID: 80054887713     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182303c7e     Document Type: Review

References (41)

1. UNAIDS. Global report: UNAIDS report on the global AIDS epidemic. 2010. Available at: http://www.unaids.org/globalreport/documents/2010 1123-GlobalReport-full-en.pdf. Accessed April 02, 2011.
2. Department of Health of South Africa. Guidelines for the Management of HIV Infected Children. 2nd ed. Department of Health of South Africa; 2010. Available at: http://www.doh.gov.za/docs/factsheets/guidelines/paediatric.pdf. Accessed March 16, 2011.
3. Meyers T, Moultrie H, Naidoo K, et al. Challenges to pediatric HIV care and treatment in South Africa. J Infect Dis. 2007;196:474-481.
4. Davies MA, Keiser O, Technau K, et al. Outcomes of the South African National Antiretroviral Treatment Programme for children: The IeDEA Southern Africa collaboration. S Afr Med J. 2009;99:730-737.
5. Fatti G, Bock P, Grimwood A, et al. Increased vulnerability of rural children on antiretroviral therapy attending public health facilities in South Africa: a retrospective cohort study. J Int AIDS Soc. 2010;13:46.
6. Janssen N, Ndirangu J, Newell ML, et al. Successful paediatric HIV treatment in rural primary care in Africa. Arch Dis Child. 2010;95: 414-421.
7. KIDS-ART-LINC Collaboration. Low risk of death, but substantial program attrition, in pediatric HIV treatment cohorts in Sub-Saharan Africa. J Acquir Immune Defic Syndr. 2008;49:523-531.
8. Reddi A, Leeper SC, Grobler AC, et al. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa. BMC Pediatr. 2007;7:13.
9. Barth RE, Tempelman HA, Smelt E, et al. Long-term outcome of children receiving antiretroviral treatment in Rural South Africa: substantial virologic failure on first-line treatment. Pediatr Infect Dis J. 2011;30:53-56.
10. Actuarial Society of South Africa. ASSA2008 AIDS and demographic model. 2011. Available at: http://aids.actuarialsociety.org.za/ASSA2008-Model-3480.htm. Accessed March 18, 2011.
11. Sutcliffe CG, van Dijk JH, Bolton C, et al. Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis. 2008;8:477-489. (Pubitemid 352005822)
12. Eley B, Davies MA, Apolles P, et al. Antiretroviral treatment for children. S Afr Med J. 2006;96:988-993.
13. Davies M-A, Egger M, Keiser O, et al. Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studies. Afr J AIDS Res. 2009;8:329-338.
14. Davies MA, Boulle A, Fakir T, et al. Adherence to antiretroviral therapy in young children in Cape Town, South Africa, measured by medication return and caregiver self-report: a prospective cohort study. BMC Pediatrics. 2008;8:34.
15. Fetzer BC, Hosseinipour MC, Kamthuzi P, et al. Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe. Malawi Trop Med Int Health. 2009;14:1-8.
16. Fenner L, Brinkhof MWG, Keiser O, et al. Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa. J Acquir Immune Defic Syndr. 2010;54:524-532.
17. Davies MA, Moultrie H, Eley B, et al. Virologic failure and second-line antiretroviral therapy in children in South Africa-The IeDEA Southern Africa Collaboration. J Acquir Immune Defic Syndr. 2011;56:270-278.
18. Cornell M, Grimsrud A, Fairall L, et al. Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007. AIDS. 2010;24:2263-2270.
19. Boulle A, Van Cutsem G, Hilderbrand K, et al. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS. 2010;24:563-572.
20. Nglazi MD, Lawn SD, Kaplan R, et al. Changes in programmatic outcomes during 7 years of scale-up at a community-based antiretroviral treatment service in South Africa. J Acquir Immune Defic Syndr. 2011;56:e1-e8.
21. Statistics South Africa. Quarterly labour force survey quarter 2. 2010. Available at: http://www.statssa.gov.za/publications/P0211/P02112nd Quarter2010.pdf. Accessed March 24, 2011.
22. Department of Health of South Africa. Guidelines for the management of HIV infected children. 2005. Available at: http://www.doh.gov.za/docs/ factsheets/guidelines/hiv/index.html. Accessed March 17, 2011.
23. Ren Y, Nuttall JJC, Egbers C, et al. Effect of Rifampicin on Lopinavir Pharmacokinetics in HIV-Infected Children With Tuberculosis. J Acquir Immune Defic Syndr. 2008;47:566-569. (Pubitemid 351442016)
24. World Health Organization. Antiretroviral therapy of HIV infection in infants and children in resource-limited settings: towards universal access. Recommendations for a public health approach. 2006. Available at: http://www.who.int/hiv/pub/guidelines/paediatric020907.pdf. Accessed April 02, 2011.
25. Glencross D, Scott LE, Jani IV, et al. CD45-assisted PanLeucogating for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry. 2002;50:69-77.
26. Geng EH, Emenyonu N, Bwana MB, et al. Sampling-based approach to determining outcomes of patients lost to follow-up in antiretroviral therapy scale-up programs in Africa. JAMA. 2008;300:506-507.
27. Bolton-Moore C, Mubiana-Mbewe M, Cantrell RA, et al. Clinical outcomes and CD4 cell response in children receiving antiretroviral therapy at primary health care facilities in Zambia. JAMA. 2007;298:1888-1899. (Pubitemid 350005233)
28. Fatti G, Grimwood A, Bock P. Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS ONE. 2010;5:e12888.
29. Sutcliffe C, Bolton-Moore C, van Dijk J, et al. Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study. BMC Pediatrics. 2010;10:54.
30. Newell ML, Coovadia H, Cortina-Borja M, et al. Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis. Lancet. 2004;364:1236-1243. (Pubitemid 39311344)
31. Bourne DE, Thompson M-L, Brody L, et al. Emergence of a peak in early infant mortality due to HIV/AIDS in South Africa. AIDS. 2009;23: 101-106.
32. Violari A, Cotton MF, Gibb DM, et al. Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med. 2008;359(21): 2233-2244.
33. World Health Organisation. Report of the WHO Technical Reference Group, Paediatric HIV/ART Care Guideline Group Meeting. 2008. Available at: http://www.who.int/hiv/pub/paediatric/WHO-Paediatric-ART-guideline-rev-mreport- 2008.pdf. Accessed April 04, 2011.
34. World Health Organisation. Antiretroviral therapy for HIV infection in infants and children: toward universal access. Recommendations for a public health approach. 2010. Available at: http://whqlibdoc.who.int/publications/2010/ 9789241599801-eng.pdf. Accessed April 08, 2011.
35. McConnell MS, Chasombat S, Siangphoe U, et al. National program scale-up and patient outcomes in a pediatric antiretroviral treatment program, Thailand, 2000-2007. J Acquir Immune Defic Syndr. 2010;54: 423-429.
36. Yotebieng M, Van Rie A, Moultrie H, et al. Six-month gains in weight, height, and CD4 predict subsequent antiretroviral treatment responses in HIV-infected South African children. AIDS. 2010;24:139-146.
37. De Baets AJ, Ramet J, Msellati P, et al. The unique features of pediatric HIV-1 in sub-Saharan Africa. Curr HIV Res. 2008;6:351-362.
38. Braun M, Kabue MM, McCollum ED, et al. Inadequate coordination of maternal and infant HIV services detrimentally affects early infant diagnosis outcomes in Lilongwe, Malawi. J Acquir Immune Defic Syndr. 2011;56:E122-E128.
39. Calmy AL, Ford N. Improving treatment outcome for children with HIV. Lancet. 2011;377:1546-1548.
40. Bock P, Boulle A, White C, et al. Provision of antiretroviral therapy to children within the public sector of South Africa. Trans R Soc Trop Med Hyg. 2008;102:905-911.
41. Keiser O, Anastos K, Schechter M, et al. Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America. Trop Med Int Health. 2008;13:870-879. (Pubitemid 351813514)